Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Multicenter randomized double-blind Phase 3 study of P-3058 in onychomycosis
2015-000561-31Phase 3Completed
- Sponsor
- Polichem
- Start
- May 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of terbinafine in onychomycosis (3 arms), sponsored by Polichem. Primary endpoint: Complete cure rate. Started May 2015; status: completed.
02
Drugs
terbinafine
03
Conditions
onychomycosis
Beyond the preview
Go deeper on 2015-000561-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-000561-31.